These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9399573)

  • 1. Antisense oligodeoxynucleotides of IGF-II selectively inhibit growth of human hepatoma cells overproducing IGF-II.
    Lin SB; Hsieh SH; Hsu HL; Lai MY; Kan LS; Au LC
    J Biochem; 1997 Oct; 122(4):717-22. PubMed ID: 9399573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation.
    Huynh H; Chow PK; Ooi LL; Soo KC
    Cell Growth Differ; 2002 Mar; 13(3):115-22. PubMed ID: 11959812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of constitutively activated and insulin-like growth factor-stimulated ERK1/2 signaling in human hepatoma cell proliferation and apoptosis: evidence for heterogeneity of tumor cell lines.
    Alexia C; Lasfer M; Groyer A
    Ann N Y Acad Sci; 2004 Dec; 1030():219-29. PubMed ID: 15659801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense oligonucleotides of hepatoma-derived growth factor (HDGF) suppress the proliferation of hepatoma cells.
    Kishima Y; Yoshida K; Enomoto H; Yamamoto M; Kuroda T; Okuda Y; Uyama H; Nakamura H
    Hepatogastroenterology; 2002; 49(48):1639-44. PubMed ID: 12397753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suramin inhibits growth and yet promotes insulin-like growth factor II expression in HepG2 cells.
    Kraft A; Reid LM; Zvibel I
    Cancer Res; 1993 Feb; 53(3):652-7. PubMed ID: 8381048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pleiotropic effect of the single clustered hepatic metastamiRs miR-96-5p and miR-182-5p on insulin-like growth factor II, insulin-like growth factor-1 receptor and insulin-like growth factor-binding protein-3 in hepatocellular carcinoma.
    Assal RA; El Tayebi HM; Hosny KA; Esmat G; Abdelaziz AI
    Mol Med Rep; 2015 Jul; 12(1):645-50. PubMed ID: 25739014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and alteration of insulin-like growth factor II-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinoma.
    Dong ZZ; Yao DF; Yao DB; Wu XH; Wu W; Qiu LW; Jiang DR; Zhu JH; Meng XY
    World J Gastroenterol; 2005 Aug; 11(30):4655-60. PubMed ID: 16094705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aflatoxin B1 modulates the insulin-like growth factor-2 dependent signaling axis.
    Ubagai T; Kikuchi T; Fukusato T; Ono Y
    Toxicol In Vitro; 2010 Apr; 24(3):783-9. PubMed ID: 20036727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alteration of the malignant phenotype of human hepatocellular carcinoma cell line Hep3B by specially synthesized oligodeoxynucleotides].
    Li Y; Liu YK; Shen YF; Sun RX
    Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):347-50. PubMed ID: 15918968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor II regulation of gene expression in rat and human hepatomas.
    Zvibel I; Brill S; Reid LM
    J Cell Physiol; 1995 Jan; 162(1):36-43. PubMed ID: 7529237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal expression of insulin-like growth factor-II and its dynamic quantitative analysis at different stages of hepatocellular carcinoma development.
    Qiu LW; Yao DF; Zong L; Lu YY; Huang H; Wu W; Wu XH
    Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):406-11. PubMed ID: 18693177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autocrine inhibition of chemotherapy response in human liver tumor cells by insulin-like growth factor-II.
    Lund P; Schubert D; Niketeghad F; Schirmacher P
    Cancer Lett; 2004 Mar; 206(1):85-96. PubMed ID: 15019164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma.
    Kim KW; Bae SK; Lee OH; Bae MH; Lee MJ; Park BC
    Cancer Res; 1998 Jan; 58(2):348-51. PubMed ID: 9443416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human hepatitis B virus transactivator X gene product regulates Sp1 mediated transcription of an insulin-like growth factor II promoter 4.
    Lee YI; Lee S; Lee Y; Bong YS; Hyun SW; Yoo YD; Kim SJ; Kim YW; Poo HR
    Oncogene; 1998 May; 16(18):2367-80. PubMed ID: 9620554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of the insulin-like growth factor-1 receptor and autocrine stimulation in human cervical cancer cells.
    Steller MA; Delgado CH; Bartels CJ; Woodworth CD; Zou Z
    Cancer Res; 1996 Apr; 56(8):1761-5. PubMed ID: 8620490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum from Chronic Hepatitis B Patients Promotes Growth and Proliferation via the IGF-II/IGF-IR/MEK/ERK Signaling Pathway in Hepatocellular Carcinoma Cells.
    Ji Y; Wang Z; Chen H; Zhang L; Zhuo F; Yang Q
    Cell Physiol Biochem; 2018; 47(1):39-53. PubMed ID: 29763915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of IGF-II in early experimental hepatocellular carcinomas and its significance in early diagnosis.
    Wang Z; Ruan YB; Guan Y; Liu SH
    World J Gastroenterol; 2003 Feb; 9(2):267-70. PubMed ID: 12532445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of insulin-like growth factor 2, insulin-like growth factor receptor 2, insulin receptor substrate 2 genes polymorphisms on susceptibility and clinicopathological features of hepatocellular carcinoma.
    Rashad NM; El-Shal AS; Abd Elbary EH; Abo Warda MH; Hegazy O
    Cytokine; 2014 Jul; 68(1):50-8. PubMed ID: 24656929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin and hormonal regulation of mRNA synthesis and abundance of autocrine growth factors: relevance to clonal growth of tumors.
    Zvibel I; Halay E; Reid LM
    Mol Cell Biol; 1991 Jan; 11(1):108-16. PubMed ID: 1846019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of growth, production of insulin-like growth factor-II (IGF-II), and expression of IGF-II mRNA of human cancer cell lines by antagonistic analogs of growth hormone-releasing hormone in vitro.
    Csernus VJ; Schally AV; Kiaris H; Armatis P
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):3098-103. PubMed ID: 10077643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.